Event Start Date: Tuesday, November 14, 2017 8:00 AM
Event End Date: Tuesday, November 14, 2017 7:00 PM
OBN (UK) and Eurasanté (FR) are delighted to announce the launch of BioSeed®, a joint venture event devised to provide a unique platform for early-stage Life Sciences companies, Technology Transfer Offices (TTO) and Universities throughout Europe seeking equity investment from Angels, High-Net-Worth individuals, specialist Crowd-Funders, and PE / VC funders genuinely interested in Seed and Stage 1 funding of early-stage companies and organisations.
BioSeed® will run as a one-day event in London on 14 November 2017 and will feature presentations and pitches by early-stage organisations and a series of pre-scheduled one-to-one meetings with potential investors.
BioSeed® is the result of a shared vision between OBN and Eurasanté; with both parties observing a lack of industry events that solely support the interaction of early-stage companies with appropriate investors at a European level.
08:00-08:30 Registration & refreshments
08:30-08:45 Welcome & introductions
08:45-09:15 Investor perspective
09:15-12:15 Themed pitching presentations
12:15-13:30 Lunch & networking
13:30-17:15 One-to-one partnering
17:30 Networking drinks
1 More London Riverside
Who Should Attend?
Life Sciences Companies
• Biotech or medtech companies seeking Seed or Series ‘A’ funding
• Both incorporated and pre-incorporated entities can apply to attend
Registration includes the opportunity to pitch to investors and participate in 1-2-1 partnering meetings
Technology Transfer Offices (TTO) and Universities
TTO’s are very welcome at the event to present on behalf of a start-up from their organisations. We envisage BioSeed® developing into a major portal through which university spin-outs can gain access to the right people in the investor ecosystem and we see TTO support as a key part of the event
The delegate rate for TTO’s is the same as for companies, however please get in contact if you wish to represent a number of companies.
All active investors interested in Seed or Series ‘A’ investment opportunities are welcome including Angels, Specialist crowd funders, HNW individuals, Venture Capitalists, Private Equity and Big pharma
Registration for investors is complimentary*. Please kindly note that registration is limited to ONE per company in the first instance